The tariff classification of Cefpodoxime (CAS-80210-62-4), Cefixime (CAS-79350-37-1), Cefdinir (CAS-91832-40-5), Cefuroxime (CAS-55268-75-2) and Granisetron (CAS-109889-09-0), imported in bulk form, from India
Issued April 26, 2007 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2941.90.5000, 2933.39.4100
Product description
The first three products, namely: Cefpodoxime, Cefixime and Cefdinir are third-generation, semi-synthetic, cephalosporin antibiotics. The fourth product, Cefuroxime, is a second-generation, semi-synthetic, cephalosporin antibiotic. All four products are indicated for use as antibacterial drugs. The fifth product, Granisetron, is an anti-nausea and anti-emetic agent. It is indicated for the prevention of nausea and vomiting associated with both emetogenic cancer chemotherapy and radiation therapy.
CBP rationale
The applicable subheading for Cefpodoxime, Cefixime, Cefdinir and Cefuroxime, imported in bulk form, will be 2941.90.5000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Antibiotics: Other: Other: Other. The applicable subheading for Granisetron, imported in bulk form, will be 2933.39.4100, HTSUS, which provides for “Heterocyclic compounds with nitrogen hetero-atom(s): Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.
Full text
N010042 April 26, 2007 CLA-2-29:RR:E:NC:2:238 CATEGORY: Classification TARIFF NO.: 2941.90.5000; 2933.39.4100 Mr. Colm F. Moynihan NorthStar Healthcare Limited 3300 Cork Airport Business Park Cork, Ireland RE: The tariff classification of Cefpodoxime (CAS-80210-62-4), Cefixime (CAS-79350-37-1), Cefdinir (CAS-91832-40-5), Cefuroxime (CAS-55268-75-2) and Granisetron (CAS-109889-09-0), imported in bulk form, from India Dear Mr. Moynihan: In your letter dated April 19, 2007, you requested a tariff classification ruling. The first three products, namely: Cefpodoxime, Cefixime and Cefdinir are third-generation, semi-synthetic, cephalosporin antibiotics. The fourth product, Cefuroxime, is a second-generation, semi-synthetic, cephalosporin antibiotic. All four products are indicated for use as antibacterial drugs. The fifth product, Granisetron, is an anti-nausea and anti-emetic agent. It is indicated for the prevention of nausea and vomiting associated with both emetogenic cancer chemotherapy and radiation therapy. The applicable subheading for Cefpodoxime, Cefixime, Cefdinir and Cefuroxime, imported in bulk form, will be 2941.90.5000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Antibiotics: Other: Other: Other.” The rate of duty will be free. The applicable subheading for Granisetron, imported in bulk form, will be 2933.39.4100, HTSUS, which provides for “Heterocyclic compounds with nitrogen hetero-atom(s): Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Roflumilast (CAS No. 162401-32-3), imported in bulk form, from Mexico
The tariff classification of Biolimus (CAS No. 851536-75-9) in bulk form, from Taiwan
The tariff classification of Ceftibuten Dihydrate (CAS No. 118081-34-8) in bulk powder form, from Italy
The tariff classification of Vilanterol Trifenatate (CAS No. 503070-58-4) in bulk powder form and Umeclidinium Bromide (CAS No. 869113-09-7) in bulk powder form, from India
The tariff classification of Omeprazole (CAS No. 73590-58-6) in bulk powder form, from Croatia
The tariff classification of Fosfomycin Tromethamol (CAS No. 78964-85-9) in bulk powder form, from Ireland
The tariff classification of Revefenacin (CAS No. 864750-70-9) in bulk form, from France
The tariff classification of Maropitant Citrate Monohydrate (CAS No. 359875-09-5) in bulk power form, from Italy
The tariff classification of Maropitant (CAS No. 147116-67-4) in bulk powder form, from Italy
The tariff classification of Difelikefalin Acetate (CAS No. 1024829-44-4) in bulk form, from Taiwan
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →